Target intelligence / Profile preview

novel transcript, sense intronic to NOVA1 (ENSG00000262119)

Target
ENSG00000262119
Molecular classification
Other (putative long non-coding RNA or transcript)
01

Overview

ENSG00000262119 is annotated in the human genome as a novel transcript located entirely within an intron of the NOVA1 gene, transcribed in the same direction as NOVA1. There is currently no evidence that it codes for a protein, nor that it acts as a validated regulatory RNA or functional target. Unlike NOVA1, which encodes a well-known neuron-specific RNA-binding protein with critical roles in alternative splicing[1][3], this particular transcript has neither demonstrated biological activity nor established links to therapeutic targeting, disease association, or pharmacological modulation. Major genomics databases recognize its sequence but do not class it as a gene encoding a receptor, enzyme, transporter, or other canonical therapeutic target class. Therefore, it should not be considered a molecular therapeutic target under current guidelines. Key notes: - The description of this entry as a "novel transcript, sense intronic to NOVA1" indicates an uncharacterized or predicted genomic feature, not an established gene or druggable target[1][3]. - Naming conventions and genomic annotations frequently include such predicted transcripts; however, without supporting functional or experimental data, these do not fulfill established target criteria[5]. - No aliases, molecular classifications, or pharmacological roles have been identified. - ENSG00000262119 is not equivalent to NOVA1 and should not be conflated with it—the latter is a functionally characterized splicing regulator involved in neuronal biology[1][3]. - If "therapeutic target" means a molecule that can presently be modulated by drugs/therapies and is relevant to disease, this entry should not be classified as such. If you intend to refer to the well-established NOVA1 protein (Neuro-oncological ventral antigen 1), refer instead to "NOVA1" (canonical gene ENSG00000139910), an RNA-binding splicing factor with a neurological regulatory role[1][3].

Other names
ENSG00000262119sense intronic transcript to NOVA1

Beyond the preview

Go deeper on novel transcript, sense intronic to NOVA1 (ENSG00000262119).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, sense intronic to NOVA1 (ENSG00000262119).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call